Testing effectiveness (Phase 2)UnknownNCT06087419
What this trial is testing
A Prospective Clinical Study of Bridging alloHSCT After Treatment With Obinutuzumab in Combination With Chidamide and Venetoclax in RR Ph-ALL and B-cell Lymphoma Patients
Who this might be right for
Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China 42